Popular Articles

White House Budget Chief Says Issue Of Abortion Coverage In Health Reform Still Under Debate
In an appearance on "Fox News Sunday," White House Office of Management and Budget Director Peter Orszag said that he is "not prepared to say explicitly" whether health care reform legislation would prohibit the use of federal tax revenue to fund abortion coverage, the New York Times reports. Orszag"s statement came in reply to a question asking whether he was prepared to say that "no taxpayer money will go to pay for abortions." Orszag said, "It"s obviously a controversial issue, and it"s one of the questions that is playing out in the debate" (Pear/Liptak, New York Times, 7/20).Sen. Judd Gregg (R-N.H.), who also appeared on "Fox News Sunday," said, "No matter what your views are on abortion, you shouldn"t ask people to use their tax dollars if they think that abortion is taking a life." Gregg added, "I would hate to see the health care debate go down over that issue. We do really need health care reform, and it has to be substantive. ... So hopefully we won"t get ourselves wrapped around the wheel of abortion in this debate" (FoxNews.com, 7/19). According to the Times, there is an ongoing behind-the-scenes debate over handling abortion coverage in health overhaul legislation. The debate affects both the public insurance plan the legislation would create and private insurers, who would receive tens of billions of dollars in federal subsidies to expand coverage for low- and moderate-income U.S. residents. A provision in the House health reform bill (HR 3200) calls for a federal advisory committee to advise the HHS secretary on an "essential benefits package" that most insurers would be required to provide. Abortion-rights opponents want abortion coverage excluded from the package, while abortion-rights advocates say the decision should be left to medical professionals. House committees working on health reform legislation have rejected Republican amendments that would have restricted abortion coverage. The Hyde Amendment, first enacted in 1976, prohibits the use of federal Medicaid money for abortion services. However, abortion-rights opponents argue that federally subsidized coverage of the uninsured would not be subject to the existing restrictions. The National Right to Life Committee issued an analysis of the House bill, stating, "There is no doubt that coverage of abortion will be mandated, unless Congress explicitly excludes abortion from the scope of federal authority to define "essential benefits."" According to the group, even if the HHS secretary did not require abortion coverage, "federal courts would interpret the broadly worded mandatory categories of coverage to include abortion" (New York Times, 7/20).

Nephrologists Indicate High Interest In AMAG Pharmaceuticals' Newly Approved Feraheme According To Latest BioTrends Report
BioTrends Research Group, Inc. released TreatmentTrends(R): US Nephrology, a syndicated report analyzing treatment practices, attitudes and perceptions based on online survey results from over 200 US Nephrologists. The survey was fielded in late May and focuses on trends in treatment patterns for renal anemia, secondary hyperparathyroidism and hyperphosphatemia.
News of the day
Sensory Impairment Among Older U.S. Workers Raises Risk Of Injury
A new study analyzing the prevalence of sensory impairment among older U.S. workers found that hearing impairment prevalence was three times that of visual impairment, and that 38 percent of older workers reported experiencing either impairment.
Cardiovascular

What Rorschach Tests Really Tell Us

One of the most well-known psychological tools is the Rorschach Inkblot Test. A viewer looks at ten inkblots, one at a time, and describes what they see. The rationale behind this test is the idea that certain aspects of the subject"s personality will be exposed as they are interpreting the images, allowing for the possible diagnosis of various psychological disorders. However, does the inkblot really reveal all? Psychological Science in the Public Interest, a journal of the Association for Psychological Science, published an exhaustive review of all data on the Rorschach (and other similar "projective" tests) in 2000. Such meta-analyses are major undertakings, so although this report is a few years old, it remains the most definitive word on the Rorschach. According to authors Scott O. Lilienfeld of Emory University, James M. Wood of University of Texas at El Paso, and Howard N. Garb of the University of Pittsburgh, despite its popularity, the Rorschach may not be the best diagnostic tool and practitioners need to be cautious in how they use this technique and interpret their results. The Rorschach Inkblot Test was developed in the 1920s, but was already mired in controversy within 30 years (critics argued that it was not always administered in a standardized way and evidence for its reliability was lacking). However, the Rorschach was revived in the 1970s with the publication of John Exner"s Comprehensive System (CS), which detailed standards and norms for analyzing results. The CS was credited with providing a concrete, scientific basis for the Rorschach tested and it became widely used in clinical and forensic settings. Proponents of the CS claimed that it also provided a wealth of information for non-patient adults and children. However, critics of this system argue that the norms established by CS are out of date and based on small sample sizes. Furthermore, the CS norms are not representative of the population and actually classify a portion of normal subjects as having pathological tendencies. Many studies have also called into question the scoring reliability of the CS; that is, a number of experiments have shown that two practitioners will score one subject very differently using the CS method. The authors observe that "disagreements can have particularly serious implications if the test results are used to reach important clinical or legal recommendations." In addition, some studies suggest that there may be a cultural bias associated with the CS. Research has shown that Blacks, Hispanics, and Native Americans score differently on a number of variables in the CS compared to White Americans. The authors note that "similar discrepancies have been reported for CS scores in Central and South American countries as well as in several European countries." These findings suggest that any CS data acquired from various racial and cultural groups should be interpreted with extreme caution. The authors acknowledge that not all the news concerning the Rorschach Inkblot Test is bad: There is evidence that this tool may be useful in identifying patients with schizophrenia, bipolar disorder, and borderline personality disorder. They note, however, that the Rorschach has not been shown to be related to Major Depressive Disorder, Antisocial Personality Disorders, or Posttraumatic Stress Disorder. Overall, the authors suggest that due to the inconsistent literature on the Rorschach Inkblot Test and other related psychological tools, practitioners should be very selective when they use these assessments and use them in ways which have strong empirical support. "Whenever possible," the authors conclude, "forensic and clinical evaluations should be based on more dependable assessment techniques, such as structured psychiatric interviews and well-validated self-report indexes." Barbara Isanski Association for Psychological Science


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):